Aspen Pharmacare Limited (APNHF)

PNK: APNHF · Real-Time Price · USD

12.24

0.00 (0.00%)

At close: May 01, 2025, 8:00 PM

Aspen Pharmacare Balance Sheet Statement

Financials in ZAR. Fiscal year is July - June.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016	Dec 31, 2015
Cash & Equivalents	12.34B	11.6B	10.91B	8.04B	6.18B	7.88B	8.55B	9.79B	7.09B	5.95B	8.98B	9.87B	11.17B	8.5B	10.71B	9.5B	10.9B	10.39B
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	9M	n/a	6M	n/a	2M	n/a	n/a	n/a	157M	n/a	n/a	n/a
Long-Term Investments	654M	222M	265M	331M	351M	n/a	622M	n/a	1.15B	n/a	1.02B	n/a	194M	n/a	143M	n/a	200M	n/a
Other Long-Term Assets	2.86B	337M	343M	352M	329M	956M	305M	1.29B	324M	718M	801M	1.48B	1.8B	2B	1.41B	1.8B	1B	1.32B
Receivables	11.46B	12.56B	10.09B	13.07B	8.24B	12.75B	7.7B	19.17B	9.05B	11.96B	8.99B	13.34B	9.64B	13.8B	12.44B	13.5B	8.8B	11.96B
Inventory	18B	18.96B	19.61B	17.68B	15.76B	15.4B	13.41B	14.3B	16.41B	14.35B	14.65B	15.57B	14.96B	13.6B	14.01B	13.2B	14.4B	13.27B
Other Current Assets	2.04B	907M	3.55B	881M	4.04B	484M	2.81B	180M	3.85B	5.69B	3.16B	6.56B	3.36B	200M	12.24B	100M	2.6B	200.5M
Total Current Assets	44.09B	44.02B	44.5B	39.67B	34.56B	36.51B	32.7B	43.45B	36.74B	37.97B	36.15B	45.35B	39.49B	36.1B	37.36B	36.3B	37.2B	35.82B
Property-Plant & Equipment	20.51B	19.64B	18.9B	17.07B	16.22B	15.91B	15.23B	14.82B	14.83B	13.15B	12.06B	11.69B	11.37B	10.1B	9.75B	9.7B	9.7B	9.32B
Goodwill & Intangibles	71.04B	73.62B	68.7B	61.92B	58.66B	62.67B	59.5B	63.02B	78.42B	64.72B	71.12B	75.27B	78.29B	73.3B	65.95B	59.3B	55.1B	57.59B
Total Long-Term Assets	95.07B	95.28B	89.78B	80.91B	76.81B	80.83B	76.98B	80.76B	96.43B	79.75B	86.16B	89.47B	92.61B	86.4B	78.23B	71.8B	67.1B	69.5B
Total Assets	139.16B	139.29B	134.28B	120.58B	111.38B	117.34B	109.68B	124.21B	133.17B	117.71B	122.32B	134.82B	132.11B	122.5B	115.59B	108.1B	104.3B	105.32B
Account Payables	4.37B	10.58B	3.97B	10.78B	3.64B	9.72B	3.3B	8.91B	3.37B	7.96B	3.93B	9.34B	4.49B	9.5B	5.18B	10B	3.5B	7.8B
Deferred Revenue	n/a	559M	11.17B	416M	7.74B	n/a	8.49B	23M	7.99B	933M	7.54B	52M	12.11B	n/a	n/a	300M	5.2B	367.3M
Short-Term Debt	11.04B	11.6B	7.74B	4.83B	11.54B	7.27B	24.48B	8.22B	6.18B	12.41B	8.26B	10.87B	11.23B	22B	18.86B	9.4B	10.9B	30.21B
Other Current Liabilities	3.38B	767M	-5.3B	958M	-5.12B	1.63B	-4.66B	2.94B	-4.63B	1.4B	-2.99B	1.9B	-3.48B	8.9B	7.81B	4.8B	-1.1B	1.81B
Total Current Liabilities	24.38B	22.94B	23.15B	16.56B	23.39B	18.62B	36.75B	20.09B	18.08B	22.71B	20.04B	22.16B	28.2B	40.4B	34.81B	24.5B	21.1B	40.18B
Long-Term Debt	24.82B	24.52B	21.38B	21.97B	10.36B	19.91B	n/a	29.26B	35.58B	31.47B	39.71B	52.51B	46.72B	29.5B	28.98B	35.7B	32.7B	13.69B
Other Long-Term Liabilities	3.19B	5.53B	2.35B	6.2B	6.46B	6.04B	7.04B	7.62B	9.85B	6.82B	8.35B	7.86B	7.81B	8.3B	9.42B	8.3B	8B	8.25B
Total Long-Term Liabilities	29.91B	30.75B	24.9B	28.81B	17.04B	26.76B	7.31B	37.77B	45.87B	39.04B	48.06B	60.37B	54.53B	37.8B	38.4B	44B	40.7B	21.94B
Total Liabilities	54.29B	53.69B	48.05B	45.37B	40.43B	45.38B	44.06B	57.85B	63.95B	61.75B	68.1B	82.53B	82.73B	78.2B	73.2B	68.5B	61.8B	62.12B
Total Debt	36.46B	36.12B	29.28B	26.8B	22.25B	27.19B	24.87B	37.48B	42.32B	43.88B	47.96B	63.38B	57.95B	51.5B	47.84B	45.1B	43.6B	43.9B
Common Stock	2.02B	1.66B	2.02B	1.67B	2.02B	1.9B	2.09B	1.86B	2.09B	1.87B	2.09B	1.88B	2.09B	1.9B	1.93B	1.9B	2.1B	2.01B
Retained Earnings	60.76B	n/a	58.13B	n/a	54.34B	n/a	50.76B	n/a	45.91B	n/a	41.25B	n/a	36.33B	n/a	31.6B	n/a	28.4B	n/a
Comprehensive Income	n/a	83.94B	26.43B	73.54B	14.82B	70.06B	13B	64.49B	21.4B	54.09B	11.05B	50.41B	11.12B	42.4B	8.83B	37.7B	12.2B	41.17B
Shareholders Equity	84.86B	85.6B	86.24B	75.21B	70.94B	71.96B	65.63B	66.35B	69.22B	55.96B	54.21B	52.29B	49.35B	44.3B	42.36B	39.6B	42.5B	43.17B
Total Investments	654M	222M	265M	331M	351M	n/a	9M	n/a	6M	n/a	2M	n/a	194M	n/a	300M	n/a	200M	n/a